Nandini Piramal: A Key Figure in Piramal Pharma with a Notable Lifestyle

Nandini Piramal's Notable Role and Achievements

Nandini Piramal is a prominent member of Piramal Pharma and the Piramal Group. Holding the position of Executive Director, Nandini spearheads the Over-The-Counter (OTC) division, transforming it into one of the fastest-growing Indian OTC companies. She has significantly enhanced the business's standing, ensuring most brands are ranked No.1 or No.2 in their respective markets.

Contributions and Leadership

• Nandini directs key functions such as Human Resources, Information Technology, and Risk Management.
• Instrumental in a historic deal in 2010, she led the sale of the domestic formulations business to Abbott Labs for $3.8 billion, marking a milestone for the Piramal Group.
• The group's diverse interests include Pharma, Financial Services, and Real Estate.

Educational Background and Personal Life

Nandini Piramal holds an MBA from Stanford University and a degree in Politics, Philosophy, and Economics from Oxford. Her background at McKinsey & Company has fortified her expertise, ultimately guiding her into the family business in 2006.

In March 2009, Nandini married Peter DeYoung, the CEO of Piramal Global Pharma, further intertwining their professional lives.

Nandini Piramal's Net Worth

Although Nandini Piramal's net worth remains undisclosed, it is noteworthy that her father, Ajay Piramal, is recognized among India's affluent billionaires, having a real-time value of USD 2.8 billion. The report for FY 2023 indicates that the consolidated revenue for the Piramal Group stands at Rs 9087 crore.